119 related articles for article (PubMed ID: 12143154)
1. [Metabolic modifications related to immunosuppressive drugs].
Ducobu J
Rev Med Brux; 2002 Jun; 23(3):156-9. PubMed ID: 12143154
[TBL] [Abstract][Full Text] [Related]
2. [Effect of immunosuppressants on lipids].
Pouteil-Noble C; Guebre F
Nephrologie; 2000; 21(7):369-72. PubMed ID: 11200615
[No Abstract] [Full Text] [Related]
3. Successful use in lung transplantation of an immunosuppressive regimen aimed at reducing target blood levels of sirolimus and tacrolimus.
Villanueva J; Boukhamseen A; Bhorade SM
J Heart Lung Transplant; 2005 Apr; 24(4):421-5. PubMed ID: 15797743
[TBL] [Abstract][Full Text] [Related]
4. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J
J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation.
Roland M; Gatault P; Doute C; Büchler M; Al-Najjar A; Barbet C; Chatelet V; Marlière JF; Nivet H; Lebranchu Y; Halimi JM
Transpl Int; 2008 Jun; 21(6):523-30. PubMed ID: 18266773
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent.
Firpi RJ; Tran TT; Flores P; Nissen N; Colquhoun S; Shackleton C; Martin P; Vierling JM; Poordad FF
Aliment Pharmacol Ther; 2004 May; 19(9):1033-9. PubMed ID: 15113371
[TBL] [Abstract][Full Text] [Related]
7. Metabolic and nutritional complications of renal transplantation.
Dumler F; Kilates C
J Ren Nutr; 2007 Jan; 17(1):97-102. PubMed ID: 17198943
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive agents: effects on glucose and lipid metabolism.
Subramanian S; Trence DL
Endocrinol Metab Clin North Am; 2007 Dec; 36(4):891-905; vii. PubMed ID: 17983927
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up?
Groetzner J; Meiser BM; Schirmer J; Koglin J; vScheidt W; Klauss V; Cremer P; Reichenspurner H; Reichart B
Transplant Proc; 2001; 33(1-2):1461-4. PubMed ID: 11267373
[No Abstract] [Full Text] [Related]
10. Cardiovascular risk factors and immunosuppressive regimen after liver transplantation.
Rossetto A; Bitetto D; Bresadola V; Lorenzin D; Baccarani U; De Anna D; Bresadola F; Adani GL
Transplant Proc; 2010 Sep; 42(7):2576-8. PubMed ID: 20832547
[TBL] [Abstract][Full Text] [Related]
11. [New immunosuppressive drugs and diabetes].
Legendre C; Thervet E; Bédrossian J
Diabetes Metab; 2001 Apr; 27(2 Pt 1):172-6. PubMed ID: 11353885
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus conversion for renal preservation in liver transplantation: not so fast.
Jensen GS; Wiseman A; Trotter JF
Liver Transpl; 2008 May; 14(5):601-3. PubMed ID: 18433068
[No Abstract] [Full Text] [Related]
13. Evaluating mechanisms of post-transplant diabetes mellitus.
van Hooff JP; Christiaans MH; van Duijnhoven EM
Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi8-vi12. PubMed ID: 15575024
[TBL] [Abstract][Full Text] [Related]
14. The metabolic effects of cyclosporin and tacrolimus.
Marchetti P; Navalesi R
J Endocrinol Invest; 2000; 23(7):482-90. PubMed ID: 11005276
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation.
Vincenti F; Rostaing L;
Contemp Clin Trials; 2005 Feb; 26(1):17-24. PubMed ID: 15837449
[TBL] [Abstract][Full Text] [Related]
16. Dyslipidemia during sirolimus therapy in patients after liver transplantation.
Kniepeiss D; Iberer F; Schaffellner S; Jakoby E; Duller D; Tscheliessnigg Kh
Clin Transplant; 2004 Dec; 18(6):642-6. PubMed ID: 15516237
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin inhibitors in heart transplantation.
Keogh A
J Heart Lung Transplant; 2004 May; 23(5 Suppl):S202-6. PubMed ID: 15093806
[TBL] [Abstract][Full Text] [Related]
18. Supratherapeutic response to ezetimibe administered with cyclosporine.
Koshman SL; Lalonde LD; Burton I; Tymchak WJ; Pearson GJ
Ann Pharmacother; 2005 Sep; 39(9):1561-5. PubMed ID: 16030077
[TBL] [Abstract][Full Text] [Related]
19. Overview of tacrolimus-based immunosuppression after heart or lung transplantation.
Reichenspurner H
J Heart Lung Transplant; 2005 Feb; 24(2):119-30. PubMed ID: 15701425
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hyperlipidemia in cardiac transplant recipients.
Bilchick KC; Henrikson CA; Skojec D; Kasper EK; Blumenthal RS
Am Heart J; 2004 Aug; 148(2):200-10. PubMed ID: 15308989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
